(MedPage Today) — In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists. In this report, we follow…
Source link : https://www.medpagetoday.com/endocrinology/obesity/119252
Author :
Publish date : 2026-01-03 15:00:00
Copyright for syndicated content belongs to the linked Source.
